-
Which test focuses on the status of the immune system and immunity?
The Immune-Frame test centers around evaluating a patient’s immune system status, assessing cellular markers, and measuring cytokine protein levels in the provided sample.
-
Do circulating tumor cells predict the site of relapse and metastases?
Our Metastat test provides this information over a period of three years. Through the Circulating Tumor Cells (CTCs), it detects markers that are linked to the likelihood of metastasis, as well as their potential location.
-
Can RGCC test for BRAF drugs?
Yes, the Onconomics and Onconomics Plus tests can be used as inhibitors for the BRAF/ MEK pathways, such as dabrafenib, vemurafenib, trametinib and sorafenib.
-
Can I send samples of specialized formulations and products for testing?
We have the capability to test substances that may not be included in our standard panel lists. If you have a specific substance that requires testing, please send us the formulation along with relevant information, and we will proceed with the assays.
In the case of combination tests, kindly provide the doctor's specifications regarding the desired ratio of each component in the combination.
-
How reliable is a negative circulating tumour cell test result for patients who have no metastasis after surgery?
The negative predictive value of RGCC’s circulating tumor cell test is approximately 86%, indicating that our test accurately returns a true negative result in 86% of cases.
-
Is ChemoSNiP a blood or buccal swab?
If you are ordering only the ChemoSNiP test, a buccal swab is suitable. However, if you are considering additional tests alongside ChemoSNiP, the patient's DNA will be isolated from a blood sample. In this scenario, a blood sample is sufficient for both tests, eliminating the need for a swab.
-
Does ChemoSNiP examine the cause of mutation?
The ChemoSNiP test offers insights into DNA mutations that may affect responses to anti-cancer drugs and treatments.
-
Can Oncotrace differentiate between benign and malignant tumors?
The Oncotrace test offers insights into circulating tumor cells, including their concentration and immunophenotype, aiding in the identification of their origin. This test serves to guide prognosis and is particularly valuable in identifying the primary tumor in cases where it's unknown.
-
How does the Immune-Frame test work?
The Immune-Frame test specifically assesses the condition of a patient's immune system by analyzing both cellular markers and cytokines secreted from the immune system.
-
How often will I need follow-up support tools?
Every three months for the first year, then every six months.
-
Do you have testimonials from doctors who have used RGCC tests?
Yes, kindly visit our testimonials page to read testimonials from both patients and healthcare professionals.
